Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
267.55
+3.58 (1.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 8,030 employees as of December 31, 2023. The number of employees decreased by 170 or -2.07% compared to the previous year.
Employees
8,030
Change (1Y)
-170
Growth (1Y)
-2.07%
Revenue / Employee
$324,438
Profits / Employee
-$40,146
Market Cap
7.64B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8,030 | -170 | -2.07% |
Dec 31, 2022 | 8,200 | 300 | 3.80% |
Dec 31, 2021 | 7,900 | -100 | -1.25% |
Dec 31, 2020 | 8,000 | -120 | -1.48% |
Dec 31, 2019 | 8,120 | -140 | -1.69% |
Dec 31, 2018 | 8,260 | 110 | 1.35% |
Dec 31, 2017 | 8,150 | -100 | -1.21% |
Dec 31, 2016 | 8,250 | 480 | 6.18% |
Dec 31, 2015 | 7,770 | 170 | 2.24% |
Dec 31, 2014 | 7,600 | -150 | -1.94% |
Dec 31, 2013 | 7,750 | 370 | 5.01% |
Dec 31, 2012 | 7,380 | 350 | 4.98% |
Dec 31, 2011 | 7,030 | 150 | 2.18% |
Dec 31, 2010 | 6,880 | 280 | 4.24% |
Dec 31, 2009 | 6,600 | 0 | - |
Dec 31, 2008 | 6,600 | 200 | 3.13% |
Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
Dec 31, 2006 | 5,400 | 200 | 3.85% |
Dec 31, 2005 | 5,200 | 0 | - |
Dec 31, 2004 | 5,200 | 400 | 8.33% |
Dec 31, 2003 | 4,800 | 200 | 4.35% |
Dec 31, 2002 | 4,600 | 300 | 6.98% |
Dec 31, 2001 | 4,300 | 500 | 13.16% |
Dec 31, 2000 | 3,800 | -300 | -7.32% |
Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
Dec 31, 1998 | 2,675 | 25 | 0.94% |
Dec 31, 1997 | 2,650 | 115 | 4.54% |
Dec 31, 1996 | 2,535 | 75 | 3.05% |
Dec 31, 1995 | 2,460 | 130 | 5.58% |
Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Henry Schein | 25,000 |
Chemed | 15,087 |
Bio-Rad Laboratories | 8,030 |
Exact Sciences | 6,600 |
HealthEquity | 3,150 |
Legend Biotech | 1,826 |
Roivant Sciences | 908 |
Ascendis Pharma | 879 |
BIO News
- 4 weeks ago - Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group - Business Wire
- 5 weeks ago - Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip - Reuters
- 2 months ago - Bio-Rad Reports First-Quarter 2024 Financial Results - Business Wire
- 2 months ago - Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad Announces Life Science Group Management Changes - Business Wire
- 2 months ago - Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - Business Wire
- 2 months ago - Bio-Rad's Chief Operating Officer Andrew Last to Retire - Business Wire